“Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC” (2025) Headache Medicine, 16(1), pp. 65–70. doi:10.48208/HeadacheMed.2025.9.